Exact Mass: 454.15221260000004
Exact Mass Matches: 454.15221260000004
Found 116 metabolites which its exact mass value is equals to given mass value 454.15221260000004
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(6R)-5,10-methenyltetrahydrofolate
C20H20N7O6 (454.14750000000004)
(6R)-5,10-methenyltetrahydrofolate is also known as Anhydroleucovorin. (6R)-5,10-methenyltetrahydrofolate is considered to be practically insoluble (in water) and acidic
2-C-hydroxy-7,8-secoeranthin beta-D-glucopyranoside
C21H26O11 (454.14750460000005)
7-[(beta-D-glucopyranosyl)oxy]-5-hydroxy-2-hydroxymethyl-8-[(2E)-4-hydroxy-3-methylbut-2-enyl]-4H-1-benzopyran-4-one
C21H26O11 (454.14750460000005)
(E)-trimethyl 1-hydroxy-3-(3-(4-hydroxy-3-methoxyphenyl)acryloyloxy)pentane-1,3,5-tricarboxylate
C21H26O11 (454.14750460000005)
Acegastrodine
C21H26O11 (454.14750460000005)
Ala Cys Asp Phe
C19H26N4O7S (454.15221260000004)
Ala Cys Phe Asp
C19H26N4O7S (454.15221260000004)
Ala Asp Cys Phe
C19H26N4O7S (454.15221260000004)
Ala Asp Phe Cys
C19H26N4O7S (454.15221260000004)
Ala Phe Cys Asp
C19H26N4O7S (454.15221260000004)
Ala Phe Asp Cys
C19H26N4O7S (454.15221260000004)
Cys Ala Asp Phe
C19H26N4O7S (454.15221260000004)
Cys Ala Phe Asp
C19H26N4O7S (454.15221260000004)
Cys Asp Ala Phe
C19H26N4O7S (454.15221260000004)
Cys Asp Phe Ala
C19H26N4O7S (454.15221260000004)
Cys Glu Phe Gly
C19H26N4O7S (454.15221260000004)
Cys Glu Gly Phe
C19H26N4O7S (454.15221260000004)
Cys Phe Ala Asp
C19H26N4O7S (454.15221260000004)
Cys Phe Asp Ala
C19H26N4O7S (454.15221260000004)
Cys Phe Glu Gly
C19H26N4O7S (454.15221260000004)
Cys Phe Gly Glu
C19H26N4O7S (454.15221260000004)
Cys Gly Glu Phe
C19H26N4O7S (454.15221260000004)
Cys Gly Phe Glu
C19H26N4O7S (454.15221260000004)
Cys Met Thr Thr
Cys Thr Met Thr
Cys Thr Thr Met
Asp Ala Cys Phe
C19H26N4O7S (454.15221260000004)
Asp Ala Phe Cys
C19H26N4O7S (454.15221260000004)
Asp Cys Ala Phe
C19H26N4O7S (454.15221260000004)
Asp Cys Phe Ala
C19H26N4O7S (454.15221260000004)
Asp Phe Ala Cys
C19H26N4O7S (454.15221260000004)
Asp Phe Cys Ala
C19H26N4O7S (454.15221260000004)
Glu Cys Phe Gly
C19H26N4O7S (454.15221260000004)
Glu Cys Gly Phe
C19H26N4O7S (454.15221260000004)
Glu Phe Cys Gly
C19H26N4O7S (454.15221260000004)
Glu Phe Gly Cys
C19H26N4O7S (454.15221260000004)
Glu Gly Cys Phe
C19H26N4O7S (454.15221260000004)
Glu Gly Phe Cys
C19H26N4O7S (454.15221260000004)
Phe Ala Cys Asp
C19H26N4O7S (454.15221260000004)
Phe Ala Asp Cys
C19H26N4O7S (454.15221260000004)
Phe Cys Ala Asp
C19H26N4O7S (454.15221260000004)
Phe Cys Asp Ala
C19H26N4O7S (454.15221260000004)
Phe Cys Glu Gly
C19H26N4O7S (454.15221260000004)
Phe Cys Gly Glu
C19H26N4O7S (454.15221260000004)
Phe Asp Ala Cys
C19H26N4O7S (454.15221260000004)
Phe Asp Cys Ala
C19H26N4O7S (454.15221260000004)
Phe Glu Cys Gly
C19H26N4O7S (454.15221260000004)
Phe Glu Gly Cys
C19H26N4O7S (454.15221260000004)
Phe Gly Cys Glu
C19H26N4O7S (454.15221260000004)
Phe Gly Glu Cys
C19H26N4O7S (454.15221260000004)
Gly Cys Glu Phe
C19H26N4O7S (454.15221260000004)
Gly Cys Phe Glu
C19H26N4O7S (454.15221260000004)
Gly Glu Cys Phe
C19H26N4O7S (454.15221260000004)
Gly Glu Phe Cys
C19H26N4O7S (454.15221260000004)
Gly Phe Cys Glu
C19H26N4O7S (454.15221260000004)
Gly Phe Glu Cys
C19H26N4O7S (454.15221260000004)
Met Cys Thr Thr
Met Met Ser Ser
Met Ser Met Ser
Met Ser Ser Met
Met Thr Cys Thr
Met Thr Thr Cys
Ser Met Met Ser
Ser Met Ser Met
Ser Ser Met Met
Thr Cys Met Thr
Thr Cys Thr Met
Thr Met Cys Thr
Thr Met Thr Cys
Thr Thr Cys Met
Thr Thr Met Cys
His-TyrMe-OH
4-methoxyphenyl 2,3,4,6-tetra-o-acetyl-beta-d-glucopyanoside
C21H26O11 (454.14750460000005)
4-METHOXYPHENYL 2,3,4,6-TETRA-O-ACETYL-BETA-D-GALACTOPYRANOSIDE
C21H26O11 (454.14750460000005)
4-methoxyphenyl 2,3,4,6-tetra-o-acetyl-alpha-d-mannopyranoside
C21H26O11 (454.14750460000005)
3-(3-Fluorophenyl)-1-[2-hydroxy-4,6-bis(phenylmethoxy)phenyl]-2-propen-1-one
LOFEPRAMINE HYDROCHLORIDE
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
Vatinoxan Hydrochloride
C20H27ClN4O4S (454.1441452000001)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist
Phenol, 4-((5-(4-chlorophenyl)-3,5-dihydro-3-((1-methylethyl)imino)-2-phenazinyl)amino)-
(6R)-5,10-methenyltetrahydrofolate
C20H20N7O6- (454.14750000000004)
A dicarboxylic acid anion arising from deprotonation of both carboxylic acid functions of (6R)-5,10-methenyltetrahydrofolic acid. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
[(2S,3R)-3-phenyl-1-(phenylmethyl)sulfonyl-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol
(2R,5S)-1,4-Dimethyl-2-hydroxy-2-(3,4-dihydroxybenzyl)-5-[(4-nitro-1H-indol-3-yl)methyl]piperazine-3,6-dione
4,7-DI(Para-ethoxyphenyl)-6-(pyridin-4-YL)-1,2,5-thiadiazolo(3,4-C)pyridine
S-hexanoyl-4-phosphopantetheine(2-)
An S-acyl-4-phosphopantetheine obtained by deprotonation of the phosphate OH groups of S-hexanoyl-4-phosphopantetheine; major species at pH 7.3.
5,7-dihydroxy-2-(hydroxymethyl)-8-(3-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-2-en-1-yl)chromen-4-one
C21H26O11 (454.14750460000005)
4-hydroxy-2-(2-hydroxypropan-2-yl)-7-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2h,3h-furo[3,2-g]chromen-5-one
C21H26O11 (454.14750460000005)
4,7-bis(acetyloxy)-4'-hydroxy-6',7-dimethyl-6,8-dioxo-4,5-dihydro-1h-spiro[2-benzopyran-3,2'-oxan]-3'-yl acetate
C21H26O11 (454.14750460000005)
(2s)-4-hydroxy-2-(2-hydroxypropan-2-yl)-7-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2h,3h-furo[3,2-g]chromen-5-one
C21H26O11 (454.14750460000005)
methyl (2e,6e)-3,5-dimethoxy-7-{2-[2-(1-methoxypropan-2-yl)-4,5-dihydro-1,3-thiazol-4-yl]-1,3-thiazol-4-yl}-4-methylhepta-2,6-dienoate
5-hydroxy-8-(4-hydroxy-3-methylbut-2-en-1-yl)-2-(hydroxymethyl)-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
C21H26O11 (454.14750460000005)
methyl 4'-ethyl-5'-oxo-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4a,7a-dihydro-1h-spiro[cyclopenta[c]pyran-7,2'-furan]-4-carboxylate
C21H26O11 (454.14750460000005)
3-{[(3r,4s,5s,6s)-6-[(3e)-4-(3,4-dihydroxyphenyl)-1-hydroxy-2-oxo(4-²h)but-3-en-1-yl]-3,4,5-trihydroxyoxan-2-yl]oxy}-4-methyloxan-2-one
C21H26O11 (454.14750460000005)
5,7-dihydroxy-2-(hydroxymethyl)-8-[(2e)-3-methyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-2-en-1-yl]chromen-4-one
C21H26O11 (454.14750460000005)
methyl (1r,4as,7r,7as)-4'-ethyl-5'-oxo-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4a,7a-dihydro-1h-spiro[cyclopenta[c]pyran-7,2'-furan]-4-carboxylate
C21H26O11 (454.14750460000005)
5-hydroxy-8-[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]-2-(hydroxymethyl)-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
C21H26O11 (454.14750460000005)
(3r,3's,4's,6's)-4,7-bis(acetyloxy)-4'-hydroxy-6',7-dimethyl-6,8-dioxo-4,5-dihydro-1h-spiro[2-benzopyran-3,2'-oxan]-3'-yl acetate
C21H26O11 (454.14750460000005)